Taking the Credit — Buy-and-build, investment grade offer, and much bother over interest cover
- Josie Shillito
Private credit’s ardour for the healthcare, IT and financial services sectors shows no sign of dimming as we straddle the boundary between H1 and H2. Not only are these businesses generative in recurring revenue, but they require flexible pools of capital to pursue their acquisitive strategies: the type only private credit can provide.
At least two €1bn plus private credit deals are floating about the market ahead of summer: a dual-track process (banks and private credit funds) on the acquisition financing of the buy-and-build heavy, Triton-owned UK specialty pharma business Pharmanovia, and a €1bn refinancing of Astorg-owned investor services business IQ-EQ, also an acquisitive business.